Loading…
Plasmid-encoded fosfomycin resistance
Fosfomycin ((-)-cis-1,2-epoxypropyl phosphonic acid) was discovered in 1968 as a secondary metabolite of several Streptomyces species. It aroused considerable interest, since it was a completely new molecule having antibacterial activity which exhibited relevant properties, such as a broad spectrum,...
Saved in:
Published in: | Antimicrobial agents and chemotherapy 1991-05, Vol.35 (5), p.791-795 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Fosfomycin ((-)-cis-1,2-epoxypropyl phosphonic acid) was discovered in 1968 as a secondary metabolite of several Streptomyces species. It aroused considerable interest, since it was a completely new molecule having antibacterial activity which exhibited relevant properties, such as a broad spectrum, covering many pathogenic and opportunistic gram-positive (Staphylococcus aureus and Streptococcus spp.) and gram-negative (Pseudomonas aeruginosa, Neisseria spp., and members of the family Enterobacteriaceae) bacteria. The use of fosfomycin has selected another type of resistant organisms which actively incorporate the drug and have a fully sensitive enolpyruvyl transferase, indicating that their mechanism of resistance is different from that of the previously described mutants. They are usually multiresistant, can transfer their resistance through conjugation or transformation, and can be made susceptible through the use of curing agents, indicating a plasmid location for the Fo super(r) determinant. |
---|---|
ISSN: | 0066-4804 1098-6596 |
DOI: | 10.1128/AAC.35.5.791 |